THE PREPARATION OF CONTROL BLOOD FOR EXTERNAL QUALITY ASSESSMENT PROGRAMS IN ORAL ANTICOAGULANT CONTROL.VAN DIJK WIERDA CA; VAN HALEM VISSER LP; VAN DER HOFF VAN HALEM R et al.1978; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1978; VOL. 39; NO 1; PP. 210-214; ABS. FR. ALLEM.; BIBL. 9 REF.Article

DECREASE OF NORMOTEST/THROMBOTEST DISCREPANCY IN NON-CONTACTED COUMARIN PLASMA AFTER GLASS OR ELLAGIC ACID ACTIVATION.GIROLAMI A; PATRASSI G; BURUL A et al.1976; BLUT; DTSCH.; DA. 1976; VOL. 33; NO 1; PP. 41-48; ABS. ALLEM.; BIBL. 1 P. 1/2Article

Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitorYANO, Y; KAMBAYASHI, J.-I; MURATA, K et al.Thrombosis research. 1992, Vol 66, Num 5, pp 583-590, issn 0049-3848Article

A PROSPECTIVE STUDY OF THE FACTORS AFFECTING ANTICOAGULANT CONTROL IN A HOSPITAL OUT-PATIENT CLINICSHEPHERD AMM; CHRISTOPHER LJ; STEVENSON IH et al.1978; POSTGRAD. MED. J.; GBR; DA. 1978; VOL. 54; NO 638; PP. 784-788; BIBL. 7 REF.Article

Etude de la thrombostabilité de poly [bis(trifluoroethoxy) phosphazene]TUR, D. R; KORSAK, V. V; VINOGRADOVA, S. V et al.Acta polymerica. 1985, Vol 36, Num 11, pp 627-631, issn 0323-7648Article

STUDIES ON COAGULATION IN NEWBORN INFANTS: LIVER MATURATION AND VITAMIN K PROCOAGULANT-INHIBITOR RELATIONSSUZUKI S.1979; J. PERINAT. MED.; DEU; DA. 1979; VOL. 7; NO 4; PP. 229-232; ABS. GER/FRE; BIBL. 13 REF.Article

DETERMINATION OF COAGULATION FACTORS (II-VII-X) AND KAOLIN PARTIAL THROMBOPLASTIN TIME BY THE LKB 8600 REACTION RATE ANALYSER.HJORTH B; KJAERSGAARD E.1977; SCAND. J. CLIN. LAB. INVEST.; NORWAY; DA. 1977; VOL. 37; NO 1; PP. 15-20; BIBL. 5 REF.Article

PREDICTING PATIENTS' WARFARIN REQUIREMENTS.ROUTLEDGE PA; DAVIES DM; BELL SM et al.1977; LANCET; G.B.; DA. 1977; NO 8043; PP. 854-855; BIBL. 11 REF.Article

Thrombin activity and oral anticoagulant therapy: a preliminary studyMARONGIU, F; SORANO, G. G; MAMELI, G et al.Haemostasis. 1989, Vol 19, Num 3, pp 142-146, issn 0301-0147Article

DER THROMBOTEST IN DEN ERSTEN LEBENSTAGEN = LE THROMBOTEST DURANT LES PREMIERS JOURS DE LA VIEWALTL H; PISTOJA F; KURZ R et al.1972; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1972; VOL. 7; NO 4; PP. 336-343; ABS. ANGL.; BIBL. 17 REF.Serial Issue

USE OF A LYOPHILIZED REFERENCE PLASMA TO COMPARE COAGULATION TEST PROCEDURES. NORMOTEST, SIMPLASTIN-A AND THROMBOTEST. = UTILISATION D'UN PLASMA LYOPHILISE DE REFERENCE POUR LA COMPARAISON DES TECHNIQUES DE COAGULATION: NORMOTEST, SIMPLASTINE-A, ET THROMBOTESTKAHAN J; NOREN I.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 34; NO 2; PP. 426-444; ABS. FR. ALLEM.; BIBL. 16 REF.Article

Agreement of Owren and Quick prothrombin times : Effects of citrate and calcium concentrations and international sensitivity index correction,HORSTI, Juha.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 5, pp 940-944, issn 0009-9147Article

DISCREPANCY BETWEEN NORMOTEST AND THROMBOTEST DURING THROMBOPLASTIN INDUCED INTRAVASCULAR COAGULATION IN RABBITS = DISCORDANCE ENTRE NORMOTEST ET THROMBOTEST PENDANT UNE COAGULATION INTRAVASCULAIRE INDUITE PAT THROMBOPLASTINE CHEZ LES LAPINSSLAASTAD RA; JEREMIC M.1972; SCAND. J. HAEMATOL.; DANM.; DA. 1972; VOL. 9; NO 4; PP. 403-410; BIBL. 19 REF.Serial Issue

THE FLETCHER FACTOR-PREKALLIKREIN DEFICIENCY: A DIAGNOSTIC TEST WHICH IDENTIFIES HETEROZYGOTES = DEFICIENCE DU FACTEUR FLETCHER (PREKALLIKREINE): UNE EPREUVE DIAGNOSTIQUE QUI A IDENTIFIE LES HETEROZYGOTESSTORMORKEN H; ABILDGAARD CF.1974; THROMBOSIS RES.; G.B.; DA. 1974; VOL. 5; NO 3; PP. 375-378; BIBL. 6 REF.Article

The prolongation of the thrombotest clotting time in newbornsHAMULYAK, K; DEVILEE, P. P; NIEUWENHUIZEN, W et al.Thrombosis research. 1988, Vol 52, Num 1, pp 45-52, issn 0049-3848Article

HEPATO-QUICK EIN NEUES THROMBOPLASTINZEITSYSTEM IM VERGLEICH ZU NORMOTEST UND THROMBOTEST = L'HEPATO-QUICK, UN NOUVEAU SYSTEME DE TEMPS DE THROMBOPLASTINE, COMPARE AU NORMOTEST ET AU THROMBOTESTFISCHER M; FALKENSAMMER C.1974; WIEN. KLIN. WSCHR.; OESTERR.; DA. 1974; VOL. 86; NO 19; PP. 577-583; ABS. ANGL.; BIBL. 25 REF.Article

Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoringIKUMA, H; WADA, H; NISHIOKA, J et al.Blood coagulation & fibrinolysis. 1999, Vol 10, Num 7, pp 429-434, issn 0957-5235Article

Hypercoagulability in a patient with hypodysfibrinogenemia : Implications for clinical managementWULF, G. G; UNTERHALT, M; BUCHWALD, A et al.Acta haematologica. 1999, Vol 101, Num 4, pp 209-212, issn 0001-5792Article